Safety of Drug Provocation Tests in Adults With and Without Clonal Mast Cell Disorders
Drug challenge is a safe and effective diagnostic tool in patients with CMD. Moreover, patients that have never had adverse reactions to NSAIDs or antibiotics before the diagnosis of CMD do not need to undergo challenge tests. In contrast, patients with a history of reactions should avoid the culprit drugs and undergo DPT to identify a safe alternative drug.
Authors
- Bianca Olivieri (ORCID: https://orcid.org/0000-0003-1690-6774)
- Giorgia Marta
- Francesco Olivieri (ORCID: https://orcid.org/0000-0001-7854-3900)
- Andrea Bernardelli (ORCID: https://orcid.org/0000-0002-4444-8339)
- Patrizia Bonadonna (ORCID: https://orcid.org/0000-0002-5703-5314)
- Ilaria Tanasi (ORCID: https://orcid.org/0000-0001-8177-374X)
- Massimiliano Bonifacio (ORCID: https://orcid.org/0000-0003-0716-1686)
- Francesca Nalin (ORCID: https://orcid.org/0000-0001-8618-9032)
- Roberta Zanotti (ORCID: https://orcid.org/0000-0003-2871-9730)
- Elisa Olivieri (ORCID: https://orcid.org/0000-0001-6060-3434)
- Francesca Norelli (ORCID: https://orcid.org/0009-0000-5260-236X)
- Valentina Gueli
- Giovanna Sfriso
Institutions
- University of Verona (IT)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- Institut thématique Génétique, génomique et bioinformatique (FR)
Publication Details
- Journal
- Allergy
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1111/all.70113
- Primary Topic
- Mast cells and histamine
- Type
- article
- Field-Weighted Citation Impact
- 0.00